Leitlinie zur Diagnostik und Therapie der tiefen Bein- und Beckenvenenthrombose^[*]

• Literatur

• 1 Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960; i: 1309-12.
• 2 Brandjes DPM. et al. Randomised trial of effects of compression stockings in patients with symptomatic proximal venous thrombosis. Lancet 1997; 349: 759. (P I)
• 3 Prandoni P. et al. Benefit of below-knee elastic compression stockings for prevention of the post-thrombotic syndrome in patients with proximal-vein thrombosis. A prospective controlled randomized study. Pathophysiol Haemost Thromb. 2002 32 (suppl 2). (P I)
• 4 Wells PS. et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350: 1795. (D I)
• 5 Bigaroni A. et al. Is clinical probability assessment of deep vein thrombosis by a score really standarized?. Thromb Haemost 2000; 83: 788. (D I)
• 6 Arcelus JJ. et al. The role of risk assessment and rapid whole-blood D-dimer testing for the diagnosis of deep vein thrombosis in symptomatic patients. JP 2002; 2: 57. (D I)
• 7 Chagnon I. et al. Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulomnary embolism. Am J Med 2002; 113: 269. (D I)
• 8 Schellong SM. et al. Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis. Thromb Haemost 2003; 89: 228. (D I)
• 9 Elias A. et al. A single complete ultrasound investigation of the venous network for the diagnostic management of patients with a clinically suspected first episode of deep venous thrombosis of the lower limb. Thromb Haemost 2003; 89: 221. (D I)
• 10 Gottlieb RH. et al. Randomized prospective study comparing routine versus selective use of sonography of the complete calf in patients with suspected deep venous thrombosis. AJR 2003; 180: 241. (D I)
• 11 Bounameaux H. et al. Rapid diagnosis of deep vein thrombosis in symptomatic patients: a comparison between four different diagnostic strategies. Thromb Haemost 1999; 82: 1360. (D I)
• 12 Van der Graaf F. et al. Exclusion of deep venous thrombosis with D-dimer testing. Comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost 2000; 83: 191. (D Ia)
• 13 Schutgens RE. et al. Combination of normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation 2003; 107: 593. (D II)
• 14 Kelly J. et al. Role of D-dimers in diagnosis of venous thromboembolism. Lancet 2002; 359: 456. (D I)
• 15 Palareti G. et al. D-dimer test performed after oral anficoagulation is stopped has a high negative predictive value for recurrence of thrombosis in patients with thrombophilic alterations and previous venous thromboembolism. Pathophysiol Haemost Thromb. 2002 32 (suppl 2). (P II)
• 16 Wells PS. et al. Assessment of deep vein thrombosis or pulmonary embolism by the combined use of clinical model and non invasive diagnostic tests. Semin Thromb Hemost 2000; 26: 643. (D I)
• 17 Comerota AJ. et al. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg 1993; 36: 359. (T Ib)
• 18 Meyerovitz MF. et al. Short-term response to thrombolytic therapy in deep venous thrombosis: predictive value of venographic appearance. Radiology 1992; 184: 345. (T Ia)
• 19 Largiadèr J. et al. Therapeutic concept for acute leg and pelvic venous thrombosis. Acta Chir Belg 2002; 102: 356. (T IIb)
• 20 O’Meara JJ. et al. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med 1994; 330: 1864. (T IIa)
• 21 The Columbus Investigators.. Low-molecularweight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657. (T Ia)
• 22 Simmoneau G. et al. A comparison of lowmolecular- weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663. (T IIa)
• 23 Harenberg J. et al. Therapie der Beinvenenthrombose mit niedermolekularen Heparinen. Deutsches Ärzteblatt 1997; 94: 2257. (T Ia)
• 24 Diuguid DL. Oral anticoagulant therapy for venous thromboembolism. N Engl J Med 1997; 336: 433. (T Ib)
• 25 Raschke RA. et al. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. Ann Intern Med 1993; 119: 874. (T Ia)
• 26 Arzneimittelkommission der deutschen Ärzteschaft, Bekanntgabe zur Heparin-induzierten Thrombozytopenie; Deutsches Ärzteblatt 96, 6 (12. Februar 1999).
• 27 Gruel Y. et al. Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia. Br J Haematol 2003; 121: 786-92.
• 28 Kovacs MJ. et al. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomised, double-blind, controlled trial. Ann Intern Med 2003; 138: 714-9.
• 29 Breddin HK. et al. Effects of a low-molecularweight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001; 344: 626. (T Ib)
• 30 Pinede L. et al. Comparion of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001; 103: 2453. (T Ib)
• 31 Hyers TM. et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119: 176S. (T Ia)
• 32 Prandoni P. et al. Residual venous thrombosis as a predictive factor for recurrent venous thromboembolism. Ann Intern Med 2002; 137: 955. (P I)
• 33 Cushman M. et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2003; 101: 1243. (T Ib)
• 34 Ridker PM. et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003; 348: 1425-34. (T Ia)
• 35 Kearon C. et al. Comparison of low-intenity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349: 631-9.
• 36 Mousa SA. Anticoagulants in thrombosis and cancer: the missing link. Expert Rev Anticancer Ther 2002; 2: 227.
• 37 Lee AYY. et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
• 38 Partsch H. et al. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg 2000; 32: 861.
• 39 Blättler W. et al. Methods of and compliance with leg compression for the treatment of symptoms of deep vein thrombosis. Phlebologie 2001; 30: 145.
• 40 Lofferer O. et al. Die ambulante Therapie der tiefen Beinvenenthrombosen mit Kompressionsverbänden (Möglichkeiten und Grenzen). In: Ehringer H. (ed). Akute tiefe Becken- und Beinvenenthrombose. Bern: Hans Huber; 1977: 184. (T IIa)
• 41 Blättler W. Ambulatory care for ambulant patients with deep vein thrombosis. J Mal Vasc 1991; 16: 137. (T IIb)
• 42 Levine M. et al. A comparison of low-molecular- weight heparin administered primary at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677. (T Ib)
• 43 Koopman MMW. et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334: 677. (T Ib)
• 44 Baldrige ED. et al. Clinical significance of freefloating venous thrombi. J Vasc Surg 1990; 11: 62. (P II)
• 45 Pacouret G. et al. Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis. Arch Intern Med 157 1997; 305-8. (P I)
• 46 Bossuyt PM. Out of hospital treatment of venous thrombosis: Socioeconomic aspects and patient’s quality of life. Hemostasis 1998; 28: 100. (T IIb)
• 47 Frank D. et al. Vergleich von ambulanter und stationärer Behandlung der akuten tiefen Beinvenenthrombose: subjektive und ökonomosche Aspekte. Schweiz Med Wschr 1998; 128: 1328. (T Ib)
• 48 Offermann M. et al. Die ambulante Therapie der akuten tiefen Beinvenenthrombose. Dtsch Med Wschr 2001; 126: 1164. (T IIb)
• 49 Gerlach H. et al. Kontrollierte Einführung der ambulanten Behandlung der akuten tiefen Beinvenenthrombose – Machbarkeitsstudie an 827 Patienten. Phlebologie 2002; 31: 77. (T IIb)
• 50 Mostbeck A. et al. Lungenembolie bei Bein- Beckenvenenthrombose: Ergebnisse einer prospektiven Studie. Diagnostik, Häufigkeit, nuklearmedizinisches und klinisches Erscheinungsbild. Wien Klin Wschr 1980; 92: 464-71.
• 51 Huisman MV. et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest 1989; 95: 498. (D II)
• 52 Partsch H. et al. Frequency of pulmonary embolism in ambulant patients with pelvic vein thrombosis: A prospective study. J Vasc Surg 1992; 16: 715. (T IIb)
• 53 Decousus H. et al. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1988; 338: 409.
• 54 Mills TD. et al. The use of vena cava filters. Hosp Med 2001; 62: 327. (T IIb)
• 55 Pradoni P. et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128. (T Ib)
• 56 Nordström M. et al. Deep venous thrombosis and occult malignancy: an epidemiological study. Br Med J 1994; 308: 891. (P I)
• 57 Netzer P. et al. Wert des Abdomenultraschalls bei tiefer Venenthrombose. Schweiz Med Wschr 1996; 126: 58S.
• 58 Rosendaal FR. et al. Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost 2001; 86: 112. (P II)
• 59 Scarabin PY. et al. on behalf of the Estrogen and ThromboEmbolism Risk (ESTHER) Study Group. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003; 362: 428-32.
• 60 Baglin T. et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003; 362: 523-6.
• 61 Hansson PO. et al. Recurrent venous thromboembolism after deep vein thrombosis. Arch Intern Med 2000; 160: 769-74.
• 62 Kearon C. et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-7.
• 63 Rey E. et al. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361: 901. (P II)
• 64 Quéré I. et al. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet 2002; 359: 747. (D II)